Analyst Price Target is $69.82
▲ +12.94% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Phreesia in the last 3 months. The average price target is $69.82, with a high forecast of $81.00 and a low forecast of $50.00. The average price target represents a 12.94% upside from the last price of $61.82.
Current Consensus is
The current consensus among 13 contributing investment analysts is to buy stock in Phreesia. This Buy consensus rating has held steady for over two years.
Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.